Highlights

  • EWL follows a defined index Investment mandate.
  • The fund reported 40 holdings on 4 November 2026.
  • Net Assets were approximately USD 3.11 billion on 5 November 2026.
  • The expense ratio is 0.50%, with semiannual distributions listed.

iShares MSCI Switzerland ETF (NYSEARCA:EWL) seeks to track the MSCI Switzerland 25/50 Index (Net). EWL closed at USD 66.56 on 4 November 2026. Net assets were approximately USD 3.11 billion on 5 November 2026. The fund’s investment universe and the weight of its individual positions define the exposure available through its shares.

Investment mandate and underlying exposure

The fund targets Swiss equities through a country-specific benchmark. Its investment universe gives exposure to companies associated with Switzerland, while individual businesses may earn Revenue in many markets. The fund’s country designation describes the Equity mandate rather than the geographic source of every company’s sales.

Healthcare and consumer staples businesses are prominent among the leading positions. Financial companies add a different Earnings profile. The number of securities should therefore be considered alongside their weights: several large companies can materially influence a portfolio with dozens of holdings.

Holdings weights and portfolio structure

As of 4 November 2026, Roche Ps Par Ag represented 14.44%; Novartis Ag represented 12.70%; Nestle Sa represented 11.38%; Ubs Group Ag represented 6.02%; Zurich Insurance Group Ag represented 4.60%; Compagnie Financiere Richemont Sa represented 3.93%.

The holdings weights describe individual security positions on the stated date and can change. Comparing the largest weights with the full holdings count helps distinguish security breadth from company concentration. A portfolio with many constituents can still be influenced materially by a smaller group of leading businesses.

Fund costs distributions and risks

The listed expense ratio is 0.50%, and distributions are scheduled semiannually. Fund distributions can vary with portfolio income and other relevant cash flows. The expense ratio describes a fund-level cost; trading shares can also involve Transaction Costs and a difference between the prices available to buyers and sellers.

Swiss equity valuations, company earnings and exchange rates can influence the fund. International sales do not remove the concentration associated with a single-country equity mandate. Foreign currency changes can also affect the U.S. dollar value of the underlying investments.

Key Insights

EWL provides a defined exposure through its benchmark mandate. Healthcare and consumer staples businesses are prominent among the leading positions. The 40 reported holdings, their individual weights and the 0.50% expense ratio are relevant to interpreting the portfolio. The mandate and underlying instruments determine which economic risks remain shared across otherwise separate positions.